Chemically modified anti-D typing serum can yield false-positive results, posing risks in blood banking. Standard ABO grouping may not adequately control these errors, challenging its widespread adoption.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: